E M Critchley. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » HumansLevodopa/administration & dosageLevodopa/therapeutic useMaleMiddle AgedParkinson Disease/complicationsParkinson Disease/drug therapySpeech Disorders/chemically induced
Substances: See more » Levodopa
Year: 1976 PMID: 55822 DOI: 10.1016/s0140-6736(76)90337-8
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321